Cargando…
Oral administration of a curcumin-phospholipid delivery system for the treatment of central serous chorioretinopathy: a 12-month follow-up study
BACKGROUND: The therapeutic effects of Meriva®, a curcumin-phospholipid (lecithin) delivery system (formulated as Norflo® tablets), on visual acuity and retinal thickness in patients with acute and chronic central serous chorioretinopathy was previously investigated in a six-month open-label study....
Autores principales: | Mazzolani, Fabio, Togni, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3666879/ https://www.ncbi.nlm.nih.gov/pubmed/23723686 http://dx.doi.org/10.2147/OPTH.S45820 |
Ejemplares similares
-
Pilot study of oral administration of a curcumin-phospholipid formulation for treatment of central serous chorioretinopathy
por: Mazzolani, Fabio
Publicado: (2012) -
The Genetic Background of Central Serous Chorioretinopathy: A Review on Central Serous Chorioretinopathy Genes
por: Giannopoulos, Konstantinos, et al.
Publicado: (2021) -
Intravitreal bevacizumab administration for the treatment of chronic central serous chorioretinopathy
por: Alishiri, Aliagha, et al.
Publicado: (2019) -
Traumatic central serous chorioretinopathy
por: Ramchandani, Suresh, et al.
Publicado: (2015) -
Traumatic central serous chorioretinopathy
por: Steeples, Laura, et al.
Publicado: (2015)